Mescaline: receptor interaction in the rat striatum.
D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects*; D001522:Behavior, Animal / Q000187:drug effects*; D002421:Caudate Nucleus / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004347:Drug Interactions; D006220:Haloperidol / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008635:Mescaline / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D009069:Movement Disorders / Q000139:chemically induced; D009433:Neural Inhibition; D010646:Phentolamine / Q000494:pharmacology; D010648:Phenylacetates / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects*; D012601:Scopolamine / Q000494:pharmacology; D013238:Stereotaxic Techniques
D006584:Hexamethonium Compounds; D010648:Phenylacetates; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D011433:Propranolol; D012601:Scopolamine; D000242:Cyclic AMP; D006220:Haloperidol; D007545:Isoproterenol; D008635:Mescaline; D002746:Chlorpromazine; D004298:Dopamine; D010646:Phentolamine